Skip to main content

Featured

Regulatory Warnings Ignored: Canadian Arm of China's Largest Bank Faces Scrutiny

The Canadian subsidiary of the Industrial and Commercial Bank of China (ICBC), the world's largest bank, has come under fire for repeatedly violating anti-money laundering regulations. Despite multiple warnings from Canada's financial intelligence unit, FINTRAC, the bank failed to address critical compliance issues. These included neglecting to file suspicious transaction reports and not treating high-risk activities with the required level of scrutiny. A routine audit in 2019 revealed several administrative violations, leading to a fine of $701,250 issued in 2021. The violations highlight systemic lapses in the bank's financial crime compliance controls, raising concerns about its commitment to combating money laundering and terrorist financing. The case underscores the importance of robust regulatory oversight and the need for financial institutions to prioritize compliance to maintain the integrity of the financial system.

article

Cancer-Causing Chemical Detected in Acne Treatments: Brands Under Scrutiny

 


In a recent alarming discovery, independent U.S. laboratory Valisure has detected high levels of the cancer-causing chemical benzene in certain acne treatments. Brands affected include:

  1. Clinique (Estee Lauder)
  2. Clearasil (Reckitt Benckiser-owned)
  3. Proactiv
  4. Target Corp.'s Up & Up
  5. PanOxyl
  6. Walgreens’ acne soap bar
  7. Walmart’s Equate Beauty acne cream

Benzene, a known carcinogen, was found not only in the acne products themselves but also in the air around incubated products, suggesting a potential inhalation risk. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging product recalls, investigations, and revised industry guidance. The situation is substantially different from previous cases where benzene impurities came from contaminated ingredients. Here, benzene originates directly from the benzoyl peroxide itself, forming at unacceptably high levels.

Consumers are advised to stay informed as regulatory responses unfold. The FDA’s reaction to Valisure’s petition remains pending. Companies implicated in this issue, including Estee Lauder, have yet to respond to media inquiries.

As we await further developments, it’s crucial to prioritize safety and informed choices when it comes to skincare products. 









Comments